Canada-based cannabis companies raised more than 3 billion Canadian dollars ($2.2 billion) in the first half of 2018 – a record amount – as the industry scales to meet expected exceptional demand when recreational sales kick off in October.
The total represents a mammoth 1,200% increase over the same period in 2017, when CA$222 million in equity and debt was raised, according to New York-based Viridian Capital Advisors.
Canada’s capital-hungry marijuana companies are increasingly turning to debt to fuel growth.
Access to debt rose from CA$30.8 million in the first half of 2017 to CA$658.2 million in the same period of 2018. (That does not include a CA$200 million loan by Alberta-based Aurora Cannabis last month.)
The number of equity financings rose from 19 in the first half of 2017 to 118 a year later, while the number of debt financings doubled from 10 to 22.
“There are still investors who believe that virtually any cannabis investment is a good one at this stage, given the nascent stage of the industry – that one can’t lose when it comes to cannabis,” said Louis Barré, president of Ottawa-based Cannab Intel, a cannabis consultancy.
He warned that other investors are much more cautious, recognizing that it already may be too late in certain parts of the sector and there’s a need to be highly selective and strategic.
“Not all companies will be winners as the industry matures and consolidates,” he said.
Matt Lamers can be reached at [email protected]
To sign up for our weekly Canada marijuana business newsletter, click here.
